The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Mr.S, thanks for the reply.
You could well be right, with so little players, the appeal of primary helium which makes up 5% of global supply is a massive attraction, providing multiple options.
IMO, hydrocarbon companies looking to reduce its carbon footprint would see this acreage as a must have. It’s incredibly exciting.
Option of the forth, with the 3rd and optional fourth paid for in equity to the driller. Another massive endorsement of confidence.
Compelling as the story is, with what appears to be effective seepage and traps/seals from the lower targets. What is of particular significance to me is that HE1 is the only way of gaining exposure to Helium in the UK and European market.
ESG funds are significant and growing and upon a successful outcome, funding and institutional exposure will catapult this company to many multiples of today’s price in double quick fashion.
Everything about this story is compelling, I just hope it’s an AIM success story which is predominantly backed by private investors.
This will of course be subject to a hostile approach in the event of success IMO, as the likes of Exxon will understands the strategic importance of the above. It may come down to a farm-in for an aggressive development and exploration/appraisal campaign.
With three/four roles of the dice (min), this is not without its risk. However, HE1 has already derisked the basin and a failure in the first well is not indicative of what we can expect for each play. As such a drop will be proceeded by forward momentum leading up to next results (well 2/3/4). Which in turn helps, with patience to manage any potential short term downside, if in fact it even exists.
With the drill bit calibrated to pick up on any shows, at this point, we shouldn’t expect for TD to produce the next news. It’s all up for grabs.
Book has just flipped positively again and should run into close. Serious buyers present.
Definitely have a buyer, the 250k sell was matched straight away. Looking very promising
Book is strengthening on little volume, perhaps unreported stake building
Just by clicking on your name and reading your historic posts tells us just about all we need to know about your credibility on this board. I for one worked you out within minutes of reading historic posts. I always try to get a feel for sentiment prior to my investment, your post today demonstrates your smoke and mirror agenda. It’s boring.
HSD,
The conversation was following earlier comms regarding the current ongoing phase three trial:
"The requirement for the UK Target Product Profile ("TPP") Rapid Breath Test requires 150 confirmed positive samples and 250 confirmed negative samples. Additional supervised breath test clinical trials from a larger group is expected to provide sufficient data to meet the desired and acceptable criteria in the TPP to roll out the COVID19 and other pathogen breath tests later this year."
FY results also said:
“Subject to completion of additional human trials, the Microtox BT would be expected to meet the criteria for UK, MHRA's Target Product Profile Rapid Breath Test which would enable us to roll out the COVID-19 and other pathogen breath tests later this year“
I appreciate with so much happening within the business that it is hard to keep up with it all, but we are definitely coming towards the end of the phase III trials.
HSD….
https://twitter.com/docmoschos/status/1409777768162906112?s=21
This should help verify below info.
Results ‘imminent’, samples being rerun a few days away to validate results prior to release. First few weeks of Q3 will be intense IMO.
Typos, really! Move along now, that’s a good boy lol
Very impressive results for FY 2020, with confirmation that we are on target for revenue of £10m for 2021, which will be upgraded in H2 of this year following the roll out of our waste water monitoring system across multiple jurisdictions.
We know that the first few weeks of Q3 will be full of fireworks, including the phase III breath test results and detail around the European and American Modern water roll out. Not to mention any update for the China JV and of course Skinlab around mid Q3.
Plenty of juice in the tank with an increasing workforce and f all ammo for the naysayers to get their teeth into that would be worth it’s salt!
Very exciting times
Just confirmed, RNS of some description expected today.
KR1 just announced blow out numbers 2 minutes ago. Watch this space, I think lol.
In accordance with AIM rules we must see an RNS update today of some description!
SNGR has flipped from being the weakest link to the strongest and running the stock up!!! Hmmm
Book just shifted favorably
The doctor confirmed yesterday on Twitter that the samples are back into the lab in the next few days for a RERUN as final validation of the results prior to release. I think those results will be as soon as next week.
https://twitter.com/docmoschos/status/1409777768162906112?s=21
Comms from today!
Wasterwater monitoring and independent validation of Covid-19 has seen ‘real time’ monitoring capabilities catapult to the forefront of government agenda. As noted at the G7, an obligation to have something in place by October should accelerate commercial roll out. Supporting articles posted on here only helps to provide important further evidence of the ‘need’!
We also have the breath test which as per Twitter today is both imminent and acceptable is terms of a rerun of samples to validate findings. This will be an important milestone towards future commercialization.
Obviously lab skin US roll out has also been discussed in US.
So in amongst the China JV/listing and wider roll out of the live Modern water detection system, the next few weeks could well be pivotal to the future of DVRG and all involved, starting tomorrow.